neurocare group AG continues expansion with opening of first UK clinic in London
14 juin 2022 10h00 HE
|
neurocare group AG
MUNICH, June 14, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
neurocare group AG Announces Expansion of Clinic Network in the US
28 avr. 2022 03h00 HE
|
neurocare group AG
MUNICH, April 28, 2022 (GLOBE NEWSWIRE) -- neurocare group AG ("neurocare" or the "Company"), a leading innovator in personalized mental health and performance empowering clinicians to deliver best...
Vital Start Health Launches COURAGE, the First Virtual Reality Enabled, Equitable Telemedicine Platform for Maternal Mental Health and Well-Being
14 avr. 2022 12h16 HE
|
Vital Start
PHILADELPHIA, April 14, 2022 (GLOBE NEWSWIRE) -- Vital Start Health, a University of Pennsylvania startup and a member of Microsoft for Startups, has launched COURAGETM as the next-generation,...
Global Psychedelic Drugs Market Research Report 2022-2025: Rising Number of Potential Candidates for BTD & Surging Popularity of Micro-dosing in Psychedelics
28 mars 2022 07h28 HE
|
Research and Markets
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "Global Psychedelic Drugs Market: Analysis By Indication (ADHD, MDD, Bipolar, Migraine, Anxiety, Parkinson's Disease, OUD, Alzheimer's Disease, AUD,...
February is Psychology Month!
03 févr. 2022 13h40 HE
|
British Columbia Psychological Association
VANCOUVER, British Columbia, Feb. 03, 2022 (GLOBE NEWSWIRE) -- February is Psychology Month, where we raise awareness about the role psychology plays in our everyday lives, the benefits of using...
Curated Mental Health to launch nationwide offices to increase access to psychedelic assisted psychotherapy
29 nov. 2021 15h54 HE
|
Curated Mental Health
New York, NY, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Curated Mental Health has announced a major plan to launch a network of offices nationwide in a bid to bring psychedelic assisted psychotherapy to all...
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
The Psychedelic Drugs Market - Global Industry Analysis (2018-2020), Growth Trends, and Market Forecast (2021-2026)
04 oct. 2021 04h33 HE
|
Research and Markets
Dublin, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The "Psychedelic Drugs Market - Global Industry Analysis (2018-2020) - Growth Trends and Market Forecast (2021-2026)" report has been added to...
Nikean Foundation announces $5 million gift to create a Psychedelic Psychotherapy Research Centre at Toronto’s University Health Network (UHN)
27 sept. 2021 06h15 HE
|
Nikean Foundation
Toronto, Ontario, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The Nikean Foundation (Nikean), a Toronto-based charitable foundation committed to the promotion of research and education in support of the...
New Study Finds Psychedelic Treatments More Effective than Typical Antidepressant Medications
13 nov. 2020 08h30 HE
|
Cybin Inc.
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Cybin Inc. (NEO: CYBN) announces the availability of a broadcast titled, “On the Trail of Better Therapeutics for Depression.” To...